CRISPR patent dispute not over yet as Emmanuelle Charpentier

Nobel Prize winner Emmanuelle Charpentier, Ph.D., and two universities have officially appealed in a dispute over certain patents for CRISPR gene editing, a long-running challenge that could have w

Related Keywords

, Crispr Cas9 , Gene Editing , Intellia Therapeutics , Iotech Patent News , Patent Challenge , Jennifer Doudna , Intellectual Property , Fierce Biotech Homepage , Biotech ,